{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:10:15Z","timestamp":1759093815763,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ijcard.2010.08.005","type":"journal-article","created":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T04:32:12Z","timestamp":1285043532000},"page":"356-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anticoagulation remains underused in prevention of stroke associated with atrial fibrillation: Insights from two consecutive national surveys"],"prefix":"10.1016","volume":"152","author":[{"given":"Yvonne","family":"Schwammenthal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan M.","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uri","family":"Goldbourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Koton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roseline","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Koren-Morag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehud","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Tanne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2010.08.005_bb0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0010","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.STR.32.2.392","article-title":"Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project)","volume":"32","author":"Lamassa","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0015","first-page":"CD000185","article-title":"Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack","author":"Saxena","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0020","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jnnp.2004.048827","article-title":"Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke","volume":"76","author":"Kimura","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0025","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0030","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0035","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1474-4422(06)70536-1","article-title":"Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study","volume":"5","author":"O'Donnell","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/01.STR.0000254622.52483.03","article-title":"Reduced poststroke mortality in patients with stroke and atrial fibrillation treated with anticoagulants: results from a Danish quality\u2013control registry of 22,179 patients with ischemic stroke","volume":"38","author":"Andersen","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0045","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"Jama"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0050","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/europace\/eul097","volume":"8","author":"Fuster","year":"2006","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0055","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1161\/01.STR.0000223048.70103.F1","volume":"37","author":"Goldstein","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0060","first-page":"3","article-title":"A national survey of acute cerebrovascular disease in Israel: burden, management, outcome and adherence to guidelines","volume":"8","author":"Tanne","year":"2006","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0065","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0140-6736(91)93206-O","article-title":"Classification and natural history of clinically identifiable subtypes of cerebral infarction","volume":"337","author":"Bamford","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0075","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0080","unstructured":"SAS Institute Inc. SAS\/STAT user's guide, version 6, fourth edition. Vol. 1, 1987:943."},{"key":"10.1016\/j.ijcard.2010.08.005_bb0085","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/bmj.323.7323.1218","article-title":"Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study","volume":"323","author":"Devereaux","year":"2001","journal-title":"Bmj"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0090","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/01.STR.31.4.822","article-title":"Adverse outcomes and predictors of underuse of antithrombotic therapy in Medicare beneficiaries with chronic atrial fibrillation","volume":"31","author":"Gage","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0095","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7326\/0003-4819-131-12-199912210-00004","article-title":"Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"131","author":"Go","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0100","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/01.STR.31.6.1217","article-title":"Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission","volume":"31","author":"Cohen","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0105","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2005.06.077","article-title":"Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation","volume":"46","author":"Waldo","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/STROKEAHA.108.516344","article-title":"Potentially preventable strokes in high\u2013risk patients with atrial fibrillation who are not adequately anticoagulated","volume":"40","author":"Gladstone","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000144085","article-title":"Adherence and quality of oral anticoagulation in cerebrovascular disease patients with atrial fibrillation","volume":"60","author":"Weimar","year":"2008","journal-title":"Eur Neurol"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0120","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/archinte.165.13.1458","article-title":"Antithrombotic therapy practices in US hospitals in an era of practice guidelines","volume":"165","author":"Tapson","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0125","first-page":"481","article-title":"Atrial fibrillation and the use of warfarin in patients admitted to an acute stroke unit","volume":"16","author":"Leckey","year":"2000","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0130","first-page":"197","article-title":"Stroke prevention in hospitalized patients with atrial fibrillation: a population-based study","volume":"10","author":"Nagpal","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0135","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/01.CIR.99.23.3028","article-title":"Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists","volume":"99","author":"Levy","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0140","doi-asserted-by":"crossref","first-page":"546S","DOI":"10.1378\/chest.08-0678","article-title":"Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)","volume":"133","author":"Singer","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0145","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0150","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2006.07.034","article-title":"Death and disability from warfarin-associated intracranial and extracranial hemorrhages","volume":"120","author":"Fang","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199507063330102","article-title":"Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. The European Atrial Fibrillation Trial Study Group","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0165","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","article-title":"Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy","volume":"348","author":"Palareti","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0170","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1161\/01.STR.0000181115.59173.42","article-title":"Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack","volume":"36","author":"Arima","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000015958","article-title":"Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: a meta-analysis and hypothesis","volume":"9","author":"Hart","year":"1999","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0180","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.279.9.657","article-title":"Acetaminophen and other risk factors for excessive warfarin anticoagulation","volume":"279","author":"Hylek","year":"1998","journal-title":"Jama"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archinte.164.2.203","article-title":"Get with the guidelines for cardiovascular secondary prevention: pilot results","volume":"164","author":"LaBresh","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.08.005_bb0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2008.11.048","article-title":"Ethical authorship and publishing","volume":"131","author":"Coats","year":"2009","journal-title":"Int J Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527310005802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527310005802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:29:37Z","timestamp":1759091377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527310005802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0167527310005802"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2010.08.005","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation remains underused in prevention of stroke associated with atrial fibrillation: Insights from two consecutive national surveys","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2010.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}